Negligence without a patient: medical negligence in clinical trials in India and the comparative study of South Korea and Australia

Authors

DOI:

https://doi.org/10.18203/2349-3259.ijct20263766

Keywords:

Medical negligence, Clinical trials, Research-related injury, No-fault compensation, Informed consent, Comparative law, India, South Korea, Australia

Abstract

Clinical research has migrated toward low- and middle-income countries, and India became a leading host before consent failures and participant deaths triggered a regulatory reckoning in 2013. The injured trial participant occupies an awkward position in medical negligence law: the intervention is experimental, its risks are by design incompletely known, and no settled standard of care governs the researcher's conduct. This study compares three jurisdictions. India, a common-law system, has adopted statutory no-fault compensation; South Korea, a civil-law system, relies on regulatory approval and indemnity insurance; Australia, a common-law system, is shaped by a landmark judicial standard and subsequent civil-liability reform. India's obligation requires sponsors to compensate trial-related injury without proof of fault, reaching injuries only associatively connected with a trial, making its principle the most protective in form. South Korea channels protection through institutional review boards and indemnity insurance, leaving the standard of care to malpractice litigation. Australia combines notification-based approval with a court-determined standard derived from Rogers v Whitaker, tempered by the customary-practice defence and supplemented by health complaints commissions. No jurisdiction performs well on compensation certainty, standard-of-care clarity and access to justice at once. The comparison supports three reforms for India: a defined standard of care, an independent compensation authority, and a clarified relationship between the no-fault remedy and the civil claim.

Metrics

Metrics Loading ...

References

Aguilera B, DeGrazia D, Rid A. Regulating international clinical research: an ethical framework for policy-makers. BMJ Glob Health. 2020;5(5):e002287. DOI: https://doi.org/10.1136/bmjgh-2020-002287

Limaye D, Langer JM, Rühling T, Fortwengel G. A critical appraisal of clinical trials conducted and subsequent drug approvals in India and South Africa. BMJ Open. 2015;5(8):e007304. DOI: https://doi.org/10.1136/bmjopen-2014-007304

Chowdhury N. Poor definitions threaten drug trial safety in India. Nat Med. 2013;19(1):15. DOI: https://doi.org/10.1038/nm0113-15

Jayaraman K. India's top drug regulator. Nat Med. 2014;20(8):802-5. DOI: https://doi.org/10.1038/nm0814-802

Lemey G, Larivière Y, Matuvanga Zola T, Maketa V, Matangila J, Mitashi P, et al. Algorithm for the support of non-related (serious) adverse events in an Ebola vaccine trial in the Democratic Republic of the Congo. BMJ Glob Health. 2021;6(6):e005726. DOI: https://doi.org/10.1136/bmjgh-2021-005726

Kessler DP, Summerton N, Graham JR. Effects of the medical liability system in Australia, the UK, and the USA. Lancet. 2006;368(9531):240-6. DOI: https://doi.org/10.1016/S0140-6736(06)69045-4

Park HW. Effect of Bioethics and Safety Act in medical research. J Korean Med Assoc. 2013;56(8):665-75. DOI: https://doi.org/10.5124/jkma.2013.56.8.665

Shin S, Jang SG, Min K, Lee W, Kim SY. The legal doctrine on the liability of physicians in medical malpractice lawsuits involving complex regional pain syndrome. J Korean Med Sci. 2018;33(9):e46. DOI: https://doi.org/10.3346/jkms.2018.33.e46

Herring J. Consistent clinical research standards benefit patients around the world. Nat Med. 2011;17(9):1036. DOI: https://doi.org/10.1038/nm0911-1036

Kamalo P, Manda-Taylor L, Rennie S. Translating ethics guidelines on compensation for research-related injuries into policy in low-income countries: lessons learnt from Malawi. BMJ Glob Health. 2017;2(Suppl 2).1. DOI: https://doi.org/10.1136/bmjgh-2016-000260.11

Sullivan R, Badwe RA, Rath GK, Pramesh CS, Shanta V, Digumarti R, et al. Cancer research in India: national priorities, global results. Lancet Oncol. 2014;15(6):e213-e222. DOI: https://doi.org/10.1016/S1470-2045(14)70109-3

Paramasivan S, Davies P, Richards A, Wade J, Rooshenas L, Mills N, et al. What empirical research has been undertaken on the ethics of clinical research in India? A systematic scoping review and narrative synthesis. BMJ Glob Health. 2021;6(5):e004729. DOI: https://doi.org/10.1136/bmjgh-2020-004729

Roy Chaudhury R, Mehta D. Regulatory developments in the conduct of clinical trials in India. Glob Health Epidemiol Genom. 2016;1:e4. DOI: https://doi.org/10.1017/gheg.2015.5

Tiwari SS, Desai PN. Unproven stem cell therapies in India: regulatory challenges and proposed paths forward. Cell Stem Cell. 2018;23(5):649-52. DOI: https://doi.org/10.1016/j.stem.2018.10.007

Evans V, Roderick P, Pollock AM. Adequacy of clinical trial evidence of metformin fixed-dose combinations for the treatment of type 2 diabetes mellitus in India. BMJ Glob Health. 2018;3:e000263. DOI: https://doi.org/10.1136/bmjgh-2016-000263

Hahm KH, Lee I. Biomedical ethics policy in Korea: characteristics and historical development. J Korean Med Sci. 2012;27 Suppl:S76-81. DOI: https://doi.org/10.3346/jkms.2012.27.S.S76

Choi EK, Kim MJ, Lim NK, Park HY. Review of the registration in the Clinical Research Information Service. J Korean Med Sci. 2016;31(1):1-8. DOI: https://doi.org/10.3346/jkms.2016.31.1.1

Choi YJ, Beck SH, Kang WY, Yoo S, Kim SY, Lee JS, et al. Knowledge and perception about clinical research shapes behavior: face-to-face survey in Korean general public. J Korean Med Sci. 2016;31(5):674-81. DOI: https://doi.org/10.3346/jkms.2016.31.5.674

Kim OJ, Park BJ, Sohn DR, Lee SM, Shin SG. Current status of the institutional review boards in Korea: constitution, operation, and policy for protection of human research participants. J Korean Med Sci. 2003;18(1):3-10. DOI: https://doi.org/10.3346/jkms.2003.18.1.3

Kang CR, Choe YJ, Yoon SJ. COVID-19 vaccine injury compensation program: lessons learned from a review of 10 implementing countries. J Korean Med Sci. 2024;39(13):e121. DOI: https://doi.org/10.3346/jkms.2024.39.e121

Roh WS, Kim DK, Jeon YH, Kim SH, Lee SC, Ko YK, et al. Analysis of anesthesia-related medical disputes in the 2009-2014 period using the Korean Society of Anesthesiologists database. J Korean Med Sci. 2015;30(2):207-13. DOI: https://doi.org/10.3346/jkms.2015.30.2.207

Park JY. Social recognition of medical accident. J Korean Med Assoc. 2011;54(10):1000-2. DOI: https://doi.org/10.5124/jkma.2011.54.10.1000

Choi IS, Choi EY, Lee IH. Challenges in informed consent decision-making in Korean clinical research: a participant perspective. PLoS One. 2019;14(5):e0216889. DOI: https://doi.org/10.1371/journal.pone.0216889

Helps C, Leask J, Barclay L, Carter S. Understanding non-vaccinating parents' views to inform and improve clinical encounters: a qualitative study in an Australian community. BMJ Open. 2019;9(5):e026299. DOI: https://doi.org/10.1136/bmjopen-2018-026299

Bradfield OM, Bismark M, Scott A, Spittal M. Medical negligence claims and the health and life satisfaction of Australian doctors: a prospective cohort analysis of the MABEL survey. BMJ Open. 2022;12(5):e059447. DOI: https://doi.org/10.1136/bmjopen-2021-059447

Bismark MM, Spittal MJ, Gogos AJ, Gruen RL, Studdert DM. Remedies sought and obtained in healthcare complaints. BMJ Qual Saf. 2011;20(9):806-10. DOI: https://doi.org/10.1136/bmjqs-2011-000109

Veness BG, Tibble H, Grenyer BF, Morris JM, Spittal MJ, Nash L, et al. Complaint risk among mental health practitioners compared with physical health practitioners: a retrospective cohort study of complaints to health regulators in Australia. BMJ Open. 2019;9(12):e030525. DOI: https://doi.org/10.1136/bmjopen-2019-030525

Austin EE, Do V, Nullwala R, Fajardo Pulido D, Hibbert PD, Braithwaite J, et al. Systematic review of the factors and the key indicators that identify doctors at risk of complaints, malpractice claims or impaired performance. BMJ Open. 2021;11(8):e050377. DOI: https://doi.org/10.1136/bmjopen-2021-050377

Bradfield OM, Bismark M, Scott A, Spittal M. Vocational and psychosocial predictors of medical negligence claims among Australian doctors: a prospective cohort analysis of the MABEL survey. BMJ Open. 2022;12(6):e055432. DOI: https://doi.org/10.1136/bmjopen-2021-055432

Downloads

Published

2026-10-26

How to Cite

Kuchipudi, A., & Jani, A. (2026). Negligence without a patient: medical negligence in clinical trials in India and the comparative study of South Korea and Australia . International Journal of Clinical Trials, 13(4), 501–508. https://doi.org/10.18203/2349-3259.ijct20263766

Issue

Section

Review Articles